EAM
MRNA icon

Erste Asset Management’s Moderna MRNA Stock Holding History

Erste Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-57,800
Closed -$5.83M – 560
2023
Q4 		$5.71M Hold
57,800
– – 0.08% 200
2023
Q3 		$5.8M Hold
57,800
– – 0.1% 193
2023
Q2 		$7.06M Hold
57,800
– – 0.12% 175
2023
Q1 		$8.52M Hold
57,800
– – 0.16% 152
2022
Q4 		$10.3M Sell
57,800
-4,263
-7% -$697K 0.22% 125
2022
Q3 		$7.33M Buy
62,063
+13,151
+27% +$2M 0.16% 152
2022
Q2 		$6.99M Buy
48,912
+16,533
+51% +$2.36M 0.16% 160
2022
Q1 		$5.66M Sell
32,379
-5,016
-13% -$844K 0.11% 205
2021
Q4 		$9.27M Sell
37,395
-22,205
-37% -$6.49M 0.17% 150
2021
Q3 		$22.6M Buy
+59,600
New +$22M 0.45% 69

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Erste Asset Management's MRNA Position: Q1 2024 in Review

Erste Asset Management sold out of Moderna (MRNA) in Q1 2024, closing a stake of 57,800 shares — an estimated $5.83M sold.

Erste Asset Management first reported a position in MRNA in Q3 2021 and held it in 10 quarters. The position peaked at $22.6M in Q3 2021. 902 funds tracked by Wall St. Rank hold MRNA as of Q1 2024.

  • Erste Asset Management reported no remaining Moderna position as of Q1 2024 after selling out during the quarter.
  • Erste Asset Management sold 57,800 Moderna shares in Q1 2024, an estimated $5.83M.
  • Erste Asset Management first reported a position in Moderna in Q3 2021 and held it in 10 quarters.
  • Erste Asset Management's Moderna position peaked at $22.6M in Q3 2021.
  • 902 funds tracked by Wall St. Rank held Moderna as of Q1 2024.

Based on Erste Asset Management's 13F filing for Q1 2024, filed 26 Nov 2024.